Home / Import refusals / AEK-1803079-9/11/1

FDA Import Refusal AEK-1803079-9/11/1 — Lilly France S.A.S.

Lilly France S.A.S. — FEI 3002807475

The FDA refused shipment AEK-1803079-9/11/1 from Lilly France S.A.S. (France) on October 3, 2022. The refused product falls under Drugs and Biologics — INSULIN BIOSYNTHETIC HUMAN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
October 3, 2022
Country
France
Product Category
Drugs and Biologics
Product Code
61PCP33 INSULIN BIOSYNTHETIC HUMAN (ANTI-DIABETIC)
Charges
75

Recent inspections

  • 1299456 (VAI Fri Sep 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1180181 (VAI Fri Jan 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1117961 (NAI Thu Jan 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1020863 (VAI Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 973033 (VAI Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • 799-1931144-1/10002/1 (Sat Nov 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-2237420-4/10002/1 (Thu Oct 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-1550093-0/10002/1 (Fri Sep 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-1059847-5/10002/1 (Fri Aug 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-7240375-3/11/1 (Fri May 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources